Subtype
Anorectal Neoplasm
CI-CAN-00001814Explore in graph →
Non-malignant504 active trials1 approved drugs6 evidence items
- NCIt
- C215222
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001814Explore in graph →
Clinical trials
2,046 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00503932 | Proton Therapy With Capecitabine for Rectal Cancer | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Mar 22, 2012 | clinicaltrials |
| NCT01064999 | A Trial of High Intensity Versus Low Intensity Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer | unknown | Phase 2 / Phase 3 | 240 | Fudan UniversityOTHER | 1 | Mar 14, 2012 | clinicaltrials |
| NCT00137878 |
| TNFerade™ Plus Chemo/Radiation/Surgery for Rectal Cancer |
| completed |
| Phase 2 |
| — |
| GenVecINDUSTRY |
| 1 |
| Feb 23, 2012 |
| clinicaltrials |
| NCT00122291 | A Study of Preoperative Radiation Therapy and Capecitabine in Locally Advanced Rectal Cancer | unknown | Phase 2 | 66 | Alberta Health servicesOTHER | 1 | Jan 19, 2012 | clinicaltrials |
| NCT00297128 | Preoperative Chemoradiation With Capecitabine and Cetuximab | completed | Phase 2 | 31 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Dec 30, 2011 | clinicaltrials |
| NCT00422864 | A Single Arm Trial of Oxaliplatin and 5FU With Concurrent Radiation in Patients With Metastatic Rectal Cancer | completed | Phase 2 | 26 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | Dec 15, 2011 | clinicaltrials |
| NCT01489332 | Induction Chemotherapy,Radiochemotherapy, Consolidation Chemotherapy in Preoperative Treatment of Rectal Cancer | unknown | Phase 2 | 60 | Institute of Oncology LjubljanaOTHER | 1 | Dec 9, 2011 | clinicaltrials |
| NCT00635466 | Phase II Trial to Evaluate Laparoscopic Surgery for Stage 0/I Rectal Carcinoma(Lap RC) | unknown | Phase 2 | 495 | Japan Society of Laparoscopic Colorectal SurgeryNETWORK | 1 | Jun 16, 2011 | clinicaltrials |
| NCT01340508 | Preoperative Concurrent Chemotherapy and Intensity Modulated Radiotherapy (IMRT) in Locally Advanced Rectal Cancer | unknown | Phase 2 | 63 | National University Hospital, SingaporeOTHER | 1 | Apr 22, 2011 | clinicaltrials |
| NCT01157806 | Palliative Radiochemotherapy Against Palliative Surgery in Stage IV Rectal Cancer With Unresectable Metastases | unknown | Phase 2 | 20 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Feb 16, 2011 | clinicaltrials |
| NCT00232453 | Preoperative Combined Radiation and Chemotherapy - Rectal Cancer | completed | Phase 2 | 34 | University Health Network, TorontoOTHER | 1 | Feb 15, 2011 | clinicaltrials |
| NCT00403624 | Evaluation of the Neoadjuvant Treatment With Oxaliplatin -UFT- Radiotherapy in Rectal Cancer | completed | Phase 1 / Phase 2 | 38 | SanofiINDUSTRY | 0 | Aug 27, 2010 | clinicaltrials |
| NCT01152710 | Capecitabine as Radiosensitising Agent in Neoadjuvant Treatment of Locally Advanced Resectable Rectal Cancer | completed | Phase 2 | 57 | Institute of Oncology LjubljanaOTHER | 1 | Jun 29, 2010 | clinicaltrials |
| NCT01142713 | The Impact of Patient Positioning and Use of Belly Board on Small Bowel and Urinary Bladder Volume Irradiated in Patients Receiving Radiotherapy for Rectal Cancer: A Prospective Phase II Study | unknown | Phase 2 | 30 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00677287 | Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer | terminated | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Dec 29, 2009 | clinicaltrials |
| NCT00677612 | Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer | terminated | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Dec 29, 2009 | clinicaltrials |
| NCT00174616 | CORE: Capecitabine, Oxaliplatin, Radiotherapy and Excision | completed | Phase 2 | 87 | SanofiINDUSTRY | 7 | Dec 7, 2009 | clinicaltrials |
| NCT00259363 | Oxaliplatin in Rectal Cancer | terminated | Phase 1 / Phase 2 | 46 | SanofiINDUSTRY | 1 | Dec 7, 2009 | clinicaltrials |
| NCT00263029 | Preoperative Radiotherapy/ Oxaliplatin/ Capecitabine Treatment For Unresectable Locally-advanced Rectal Cancer(PROCTFUL) | completed | Phase 2 | 18 | SanofiINDUSTRY | 0 | Sep 18, 2009 | clinicaltrials |
| NCT00964457 | Treatment of Patients With Advanced Rectum Cancer With Capecitabine and Oxaliplatin Before, Under and After Radiation and With Adding Cetuximab to K-RAS Wild-type Patients | unknown | Phase 2 | 60 | Copenhagen University Hospital at HerlevOTHER | 1 | Aug 25, 2009 | clinicaltrials |
| NCT00063427 | Study Evaluating MAC-321 in Colorectal Cancer | completed | Phase 2 | 45 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 0 | Aug 21, 2009 | clinicaltrials |
| NCT00072748 | Study Evaluating EKB-569 in Advanced Colorectal Cancer | completed | Phase 2 | 63 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 0 | Aug 21, 2009 | clinicaltrials |
| NCT00330915 | A Study of Pemetrexed and Folic Acid Given Before Surgery (Neoadjuvant Treatment) to Patients With Rectal Cancer. | completed | Phase 2 | 37 | Eli Lilly and CompanyINDUSTRY | 1 | Jul 21, 2009 | clinicaltrials |
| NCT00254683 | Use of Positron Emission Tomography/Computed Tomography (PET/CT) to Assess Tumor Response to Neoadjuvant Treatment for Distal Rectal Cancer | unknown | Phase 2 | 100 | University of Sao PauloOTHER | 1 | Apr 14, 2009 | clinicaltrials |
| NCT00808379 | Concurrent Chemo-Radiotherapy Versus Radiotherapy With Boost in Locally Advanced Unresectable Rectal Cancers | unknown | Phase 2 | 90 | Tata Memorial HospitalOTHER_GOV | 1 | Dec 15, 2008 | clinicaltrials |
| NCT00235898 | Clinical Trial in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 300 | Mast Therapeutics, Inc.INDUSTRY | 5 | Aug 25, 2008 | clinicaltrials |
| NCT00457327 | Pilot Study for Evaluation of the Need for Protective Ileostomy After Low Anterior Resection Due to Rectal Cancer | terminated | Phase 2 | 40 | Heidelberg UniversityOTHER | 1 | Jun 5, 2008 | clinicaltrials |
| NCT00590278 | A Phase-II Study Of TOMUDEX Plus Radiotherapy In Subject With Inoperable or Recurrent Rectal Cancer(TOMUDEX) | completed | Phase 2 | 49 | AstraZenecaINDUSTRY | 1 | Jan 25, 2008 | clinicaltrials |
| NCT00176787 | Radiation Therapy With Capecitabine in Rectal Cancer | terminated | Phase 2 | 30 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jan 10, 2008 | clinicaltrials |
| NCT00081627 | Clinical Trial in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 48 | Mast Therapeutics, Inc.INDUSTRY | 2 | Nov 27, 2007 | clinicaltrials |
| NCT00557713 | XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma | unknown | Phase 2 | 44 | Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socialsOTHER | 1 | Nov 14, 2007 | clinicaltrials |
| NCT00506623 | Preoperative Chemoradiotherapy With Capecitabine Plus Irinotecan in Rectal Cancer | unknown | Phase 2 | 48 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 25, 2007 | clinicaltrials |
| NCT00506844 | Preoperative Chemoradiotherapy With Cetuximab in Rectal Cancer(ERBIRIX) | unknown | Phase 2 | 40 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 25, 2007 | clinicaltrials |
Data updated 23 days agoSource updated Mar 22, 2012source: clinicaltrials